Sarah P Blagden (Sarah Blagden)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

RNA biology

Trials

University of Oxford

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oxford May 01 2015

United Kingdom

Associate Professor of Experimental Oncology :: Oncology

Publications

Miriam Dixon-Zegeye, Rachel Shaw, Linda Collins, Kendra Perez-Smith, Alexander Ooms, Maggie Qiao, Pan Pantziarka, Louise Izatt, Marc Tischkowitz, Rachel E Harrison, Angela George, Emma R Woodward, Simon Lord, Lara Hawkes, D Gareth Evans, James Franklin, Helen Hanson, Sarah P Blagden
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol. Trials 25 (1) (2024)
Miriam Dixon-Zegeye, Rachel Shaw, Linda Collins, Kendra Perez-Smith, Alexander Ooms, Maggie Qiao, Pan Pantziarka, Louise Izatt, Marc Tischkowitz, Rachel E Harrison, Angela George, Emma R Woodward, Simon Lord, Lara Hawkes, D Gareth Evans, James Franklin, Helen Hanson, Sarah P Blagden
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol. Trials 25 (1) (2024)
Miriam Dixon-Zegeye, Rachel Shaw, Linda Collins, Kendra Perez-Smith, Alexander Ooms, Maggie Qiao, Pan Pantziarka, Louise Izatt, Marc Tischkowitz, Rachel E Harrison, Angela George, Emma R Woodward, Simon Lord, Lara Hawkes, D Gareth Evans, James Franklin, Helen Hanson, Sarah P Blagden
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol. Trials 25 (1) (2024)
Jason John Luke, Marwan Fakih, Charles Schneider, E Gabriela Chiorean, Johanna Bendell, Rebecca S Kristeleit, Razelle Kurzrock, Sarah P Blagden, Irene Brana, Laura W Goff, Kevin O'Hayer, Ryan Geschwindt, Michael Smith, Feng Zhou, Aung Naing
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors. British journal of cancer (2023)
Jason John Luke, Marwan Fakih, Charles Schneider, E Gabriela Chiorean, Johanna Bendell, Rebecca S Kristeleit, Razelle Kurzrock, Sarah P Blagden, Irene Brana, Laura W Goff, Kevin O'Hayer, Ryan Geschwindt, Michael Smith, Feng Zhou, Aung Naing
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors. British journal of cancer (2023)
Rebecca S Kristeleit, Ruth Plummer, Robert Jones, Louise Carter, Sarah P Blagden, Debashis Sarker, Tobias Arkenau, Thomas R Jeffry Evans, Sarah Danson, Stefan N Symeonides, Gareth J Veal, Barbara J Klencke, Mark M Kowalski, Udai Banerji
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer. British journal of cancer (2023)
Jason John Luke, Marwan Fakih, Charles Schneider, E Gabriela Chiorean, Johanna Bendell, Rebecca S Kristeleit, Razelle Kurzrock, Sarah P Blagden, Irene Brana, Laura W Goff, Kevin O'Hayer, Ryan Geschwindt, Michael Smith, Feng Zhou, Aung Naing
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors. British journal of cancer (2023)
Jason John Luke, Marwan Fakih, Charles Schneider, E Gabriela Chiorean, Johanna Bendell, Rebecca S Kristeleit, Razelle Kurzrock, Sarah P Blagden, Irene Brana, Laura W Goff, Kevin O'Hayer, Ryan Geschwindt, Michael Smith, Feng Zhou, Aung Naing
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors. British journal of cancer (2023)
Robert Jones, Ruth Plummer, Victor Moreno, Louise Carter, Desamparados Roda, Elena Garralda, Rebecca S Kristeleit, Debashis Sarker, Hendrick-Tobias Arkenau, Patricia Roxburgh, Harriet Sarah Walter, Sarah P Blagden, Alan Anthony, Barbara J Klencke, Mark M Kowalski, Udai Banerji
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sarah P Blagden, Ly-Mee Yu, Stephanie Ellis, Helen Hughes, Abeer M Shaaban, Jonathan Fennelly-Barnwell, Mark P Lythgoe, Alison M Cooper, Francois M Maignen, Sean W Buckland, Pamela R Kearns, Louise C Brown, null null
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective. British journal of cancer (2022)
Shibani Nicum, Sarah P Blagden
PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Sarah P Blagden, Mark A Bayfield, Cécile Bousquet-Antonelli
A decade of LARP society. RNA biology 18 (2) (2021)
Hagen Schwenzer, Erica De Zan, Mustafa Elshani, Ruud van Stiphout, Mary Kudsy, Josephine Morris, Valentina Ferrari, In Hwa Um, James Chettle, Farasat Kazmi, Leticia Campo, Alistair Easton, Sebastian Nijman, Michaela Serpi, Stefan N Symeonides, Ruth Plummer, David J Harrison, Gareth Bond, Sarah P Blagden
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Ping Zhang, Isaac Kitchen-Smith, Lingyun Ivy Xiong, Giovanni Stracquadanio, Katherine Brown, Philipp H Richter, Marsha D Wallace, Elisabeth Bond, Natasha Sahgal, Samantha Moore, Svanhild Nornes, Sarah De Val, Mirvat Surakhy, David Sims, Xuting Wang, Douglas A Bell, Jorge Zeron-Medina, Yanyan Jiang, Anderson J Ryan, Joanna L Selfe, Janet Shipley, Siddhartha Kar, Paul David Peter Pharoah, Chey Loveday, Rick Jansen, Lukasz Filip Grochola, Claire Palles, Andrew Protheroe, Val Millar, Daniel V Ebner, Meghana S Pagadala, Sarah P Blagden, Timothy S Maughan, Enric Domingo, Ian P M Tomlinson, Clare Turnbull, Hannah Carter, Gareth L Bond
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response. Cancer research 81 (7) (2021)
Zhiyuan Hu, Paula Cunnea, Zhe Zhong, Haonan Lu, Oloruntoba I Osagie, Leticia Campo, Mara Artibani, Katherine Nixon, Jennifer Ploski, Laura Santana Gonzalez, Abdulkhaliq Alsaadi, Nina Wietek, Stephen Damato, Sunanda Dhar, Sarah P Blagden, Christopher Yau, Joanna Hester, Ashwag Albukhari, Eric O Aboagye, Christina Fotopoulou, Ahmed Ahmed
The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2021)
Farasat Kazmi, Shibani Nicum, Rene L Roux, Laura Spiers, Chat Gnanaranjan, Ajithkumar Sukumaran, Hani Gabra, Essam Ghazaly, Nigel W McCracken, David J Harrison, Sarah P Blagden
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Hagen Schwenzer, Mai Abdel Mouti, Pia Neubert, Josephine Morris, Joanne D Stockton, Sarah Bonham, Martin Fellermeyer, James Chettle, Roman Fischer, Andrew D Beggs, Sarah P Blagden
LARP1 isoform expression in human cancer cell lines. RNA biology 18 (2) (2020)
Andrea J Berman, Carson C Thoreen, Zinaida Dedeic, James Chettle, Philippe P Roux, Sarah P Blagden
Controversies around the function of LARP1. RNA biology 18 (2) (2020)
Amit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, John Nemunaitis, Lynda D Roman, Sarah P Blagden, Susana Banerjee, William P McGuire, Sharad Ghamande, Michael J Birrer, Gini F Fleming, Merry-Jennifer Markham, Hal W Hirte, Diane M Provencher, Bristi Basu, Rebecca Kristeleit, Deborah K Armstrong, Benjamin Schwartz, Patricia Braly, Geoff D Hall, Kenneth P Nephew, Simone Jueliger, Aram Oganesian, Sue Naim, Yong Hao, Harold Keer, Mohammad Azab, Daniela Matei
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (5) (2019)
Lesley Howells, Nicholas J Hulbert-Williams, Sarah P Blagden
New challenges in psycho-oncology: Using drug development methodology to improve survivorship and supportive care intervention trials. Psycho-oncology 28 (7) (2019)

Sarah P Blagden.css-eqlu8i{font-size:small;padding-left:4px;} (Sarah Blagden)

Publication Activity (10 Years)

Top Topics

Top Venues

Sarah P Blagden (Sarah Blagden)